Abstract-Research suggests that oxygen desaturation and sleep stage during obstructive sleep apnea (OSA) are related to the magnitude of high blood pressure (BP) in a laboratory setting. However, in a clinical setting, these associations have not been well studied. We used a noninvasive oscillometric BP measurement device to investigate the association between oxygen-triggered BP levels at the end of each OSA episode and the characteristics of the preceding OSA episode. 
O bstructive sleep apnea (OSA) has been associated with a risk of hypertension 1, 2 and cardiovascular disease (CVD). 3, 4 In particular, OSA has demonstrated a critical impact on nocturnal blood pressure (BP) levels and fluctuations 5 and may be closely related to nocturnal cardiovascular events. 6, 7 Experiments using intra-arterial BP monitoring or continuous finger BP measurements reported that an OSA episode causes an acute transient BP elevation (ie, BP surge) at the time of its termination, resulting in exaggerated high BP. 8, 9 The magnitude of the high BP may be dependent on characteristics of the preceding OSA episode, including the specific sleep stage and resultant oxygen desaturation. 10, 11 BP surge is a reaction to chemoreflex-mediated hypoxic stimulation of sympathetic activity, 12, 13 which declines progressively during deeper stages of non-rapid eye movement (REM) sleep and increases during REM sleep, as compared with that during wakefulness. 14 Most clinical studies on the contribution of OSA to BP only investigated the association between the severity of OSA, assessed with the apnea-hypopnea index (AHI) or oxygen desaturation index, and average BP levels during a sleep period. No report has examined transient BP elevation at the time of OSA episode termination under varied conditions according to the magnitude of desaturation and its duration in a clinical setting because invasive or complicated BP measurements, such as peripheral arterial tonometry, are needed to obtain BP readings induced by an OSA episode.
We recently developed an oxygen-triggered nocturnal BP (TNP) monitoring method that initiates measurement when the oxygen saturation falls below a variable threshold. This method can be used to evaluate the BP level at the end of an OSA episode. [15] [16] [17] [18] The aim of this study was to investigate the association between BP level at the end of an OSA episode using the newly developed TNP method and the characteristics of the preceding OSA episode, including OSA duration, lowest oxygen saturation (SpO 2 ) during OSA, and sleep stage, in a clinical setting.
Subjects and Methods
All data and supporting materials have been provided with the published article.
Subjects
In total, 55 consecutive suspected OSA outpatients were recruited at Mitsubishi Mihara Hospital between January 2013 and April 2014. All patients underwent simultaneous overnight polysomnography and TNP. OSA was diagnosed as AHI ≥15 during polysomnography or AHI ≥5 during polysomnography with sleep-disordered breathing-related complaints, such as unintentional sleep episodes during wakefulness, daytime sleepiness, and snoring. 19 All patients were questioned about regular medications and medical histories, including treatment for hypertension, and drinking and smoking habits. After exclusion of 13 participants without diagnosed OSA, 42 subjects (36 men and 6 women with a mean age±SD of 63.5±12.5 years and a mean body mass index±SD of 26.6±5.8 kg/m 2 ), each with a complete data set, were included in our analyses. Of these, 34 had hypertension (defined as taking antihypertensive medication and having systolic BP [SBP] ≥140 and diastolic BP ≥90 mm Hg) 20 ; 12 had diabetes mellitus (defined as taking antidiabetic medication); 29 had dyslipidemia (defined as taking antihyperlipidemic medication); 6 were current smokers (defined as having a current smoking habit regardless of the number of cigarettes smoked per day); and 14 were habitual drinkers (defined as drinking alcohol ≥5 days per week regardless of the amount consumed). The institutional review board of the Jichi Medical University School of Medicine approved this study, and written informed consent was obtained from all participants. SpO 2 ) during OSA, and oxygen-triggered BP measurements. All were based on polysomnography recoding. B, Hypoxia-peak systolic BP (SBP) was defined as the maximum SBP value among 3 measurements during a single triggered episode. Mean nocturnal SBP was defined as the average nocturnal BP measured using the fixed-interval function. Nocturnal SBP surge was defined as the difference between the hypoxia-peak SBP and the mean nocturnal SBP. The minimum nocturnal SBP was the lowest value among all nocturnal SBP values measured by either the fixed-interval or oxygen-triggered function. Maximum value of SBP surge was defined as the difference between the hypoxia-peak SBP and the minimum nocturnal SBP.
Polysomnography Examination and TNP Monitoring
All patients underwent overnight polysomnography using the Alice 5 System (Respironics, Murrysville, PA), as described previously. 21 Sleep staging was performed according to the criteria of Rechtschaffen and Kales. 22 Electroencephalography arousals were scored according to the standard criteria established by the American Sleep Disorders Association. 23 Apnea was defined as the continuous cessation of airflow for >10 seconds, whereas hypopnea was defined according to the recommendations of the American Academy of Sleep Medicine Task Force. 24 AHI was calculated on the basis of the total number of episodes of apnea and hypopnea per hour of sleep.
We simultaneously assessed nocturnal BP and overnight polysomnography using 2 different BP measurement functions of the TNP system. The fixed-interval function measures BP using a HEM-780 system (Omron Healthcare Co, Ltd, Kyoto, Japan) at fixed intervals, including 2, 3, and 4 am. The oxygen-triggered function initiates BP measurement when the SpO 2 level (continuously monitored with pulse oximetry) falls below a variable threshold. Once triggered, the TNP system takes 3 measurements-SBP, diastolic BP, and pulse rate (PR)-at 15-second intervals.
Definition of OSA and BP Parameters
We added the timing of BP measurements to the polysomnography recording using a vibration sensor and identified OSA episodes that initiated oxygen-triggered BP measurements ( Figure 1A ). We identified non-REM stages 1 and 2 sleep, slow-wave sleep, and REM sleep at the onset of an OSA episode. OSA durations were measured, and the lowest SpO 2 during an OSA episode was identified on the polysomnography recording. The mean nocturnal SBP, diastolic BP, and PR were defined as the averages of readings measured using the fixed-interval function. We calculated the average of 3 BP values measured with the oxygen-triggered function as the BP level at the end of an OSA episode. We defined the hypoxia-peak SBP as the maximum SBP value among the 3 SBP measurements and defined nocturnal SBP surge as the difference between the hypoxia-peak SBP and the mean nocturnal SBP. 18 The minimum nocturnal SBP was the lowest SBP value among all nocturnal SBP values measured using either the fixed-interval or oxygen-triggered function. We defined maximum value of SBP surge as the difference between the hypoxia-peak SBP and the minimum nocturnal SBP ( Figure 1B ).
Statistical Analysis
Continuous variables were expressed as mean±SD, and categorical variables were summarized as numbers and percentages. Normality of continuous variables was examined with the Shapiro-Wilk W test. Differences among the 4 sleep stage groups were analyzed with the Kruskal-Wallis test, and the Steel-Dwass post hoc test was used for multiple comparison testing. The relationship between 2 variables was evaluated using Spearman rank correlation. For multivariate analysis, we used a linear mixed model for repeated BP measurements within participants. To investigate the association between hypoxia-peak SBP and parameters of the preceding OSA episode (OSA duration, lowest SpO 2 , during OSA, and sleep stage [REM sleep or non-REM sleep]), model 1 included participants with a random-effect interaction term, age, sex, and factors that were significantly correlated with each oxygen-triggered BP parameter as determined by variables with P<0.1 in Spearman test. Next, we added sleep stage as a covariate in model 1 to investigate the association between lowest SpO 2 during OSA (model 2) or OSA duration (model 3) and each oxygen-triggered BP parameter. In addition, we assessed the interaction among sleep stage, OSA duration, and lowest SpO 2 during OSA by multivariate analysis using the interaction terms REM sleep×OSA duration, REM sleep×lowest SpO 2 during OSA, and OSA duration×lowest SpO 2 during OSA. We investigated the association of the ratio of REM sleep/non-REM sleep overnight with each oxygen-triggered BP parameter, using model 1. In addition, we investigated the association of PR change during BP surges with parameters of the preceding OSA episode. The relationship between clinical characteristics of participants and PR change during BP surges was assessed using Spearman rank correlation. In multivariate analysis, the model included participants with a random-effect term, age, sex, and factors that were significantly correlated with each PR change during BP surge as determined by variables with P<0.1 in Spearman test. P<0.05 was considered statistically significant. All statistical analyses were performed using JMP 10 statistical software (SAS Institute, Inc, Cary, NC). Habitual drinker, n (%) 14 (33) Hypertension, n (%) 34 (81) Diabetes mellitus, n (%) 12 (29) Dyslipidemia, n (%) 29 (69) AF, n (%) 3 (7) Antihypertensive medication, n (%) 29 (69) Calcium channel blocker, n (%) 25 (60) Angiotensin II receptor antagonist, n (%) 14 (33) Angiotensin-converting enzyme inhibitor, n (%) 3 (7) Thiazide diuretic, n (%) 6 (14) Aldosterone antagonist, n (%) 3 (7) β-Blocker, n (%) Data are expressed as mean±SD or number and percentage. AF indicates atrial fibrillation; AHI, apnea-hypopnea index; BMI, body mass index; BP, blood pressure; DBP, diastolic BP; PR, pulse rate; REM, rapid eye movement; SBP, systolic BP; SpO 2 , oxygen saturation; SPT, sleep period time; SWS, slow-wave sleep; TST, total sleep time; and WASO; wake time after sleep onset.
Results
Clinical characteristics of all patients, polysomnography findings, and BP measured with the fixed-interval function are presented in Table 1 . Of the 42 patients, 4 had mild OSA (5≤AHI<15 with sleep-disordered breathing-related complaints), 19 had moderate OSA (15≤AHI<30), and 19 had severe OSA (30≤AHI). AHI, REM AHI, and non-REM AHI in each patient are shown in Table S1 in the online-only Data Supplement.
We obtained a total of 258 BP measurements at the end of OSA episodes in the 42 patients. Table 2 Figure 2 shows that the duration of OSA was significantly correlated with hypoxia-peak SBP (ρ=0.289; P<0.001). The lowest SpO 2 during OSA was significantly negatively correlated with hypoxia-peak SBP (ρ=−0.216; P=0.001).
Associations between sleep stage, OSA duration, and lowest SpO 2 during OSA and BP surge are shown in Figure S1 . Table 3 shows Spearman rank correlations between clinical characteristics, REM sleep, and oxygen-triggered BP parameters. Current smoker status, hypertension, and atrial fibrillation were associated with hypoxia-peak SBP. Current smoker status was associated with nocturnal SBP surge, and female sex, body mass index, and use of antihypertensive medication were negatively associated with nocturnal SBP surge. Current smoker status and diabetes mellitus were associated with maximum value of SBP surge, and age was negatively associated with maximum value of SBP surge. REM was significantly associated with all oxygen-triggered BP parameters.
In the multivariate-linear mixed model, REM sleep, OSA duration per second, and lowest SpO 2 % were associated with increased hypoxia-peak SBP, nocturnal SBP surge, and maximum value of SBP surge (model 1 in Table 4 ). After adding REM sleep as a covariate to model 1, the lowest SpO 2 % was associated with increased hypoxia-peak SBP, nocturnal SBP surge, and maximum value of SBP surge (model 2); however, these associations were not observed for the 1-second increment of OSA duration (model 3). There was no significant interaction among REM sleep, OSA duration, and lowest SpO 2 during OSA (Table S2 ). The ratio of REM sleep/non-REM sleep had no significant impact on either hypoxia-peak SBP, nocturnal SBP surge, or the maximum value of SBP surge (Table S3) .
Current smoker status and habitual drinker status were associated with PR changes nocturnal SBP surge, whereas female sex, body mass index, and the presence of hypertension, diabetes mellitus, and dyslipidemia were negatively associated with PR changes during nocturnal SBP surge. Female sex, current smoker status, and diabetes mellitus were associated with PR changes during the maximum value of SBP surge, and age was negatively associated with PR changes during the maximum value of SBP surge (Table S4 ).
In the multivariate-linear mixed model, REM sleep and lowest SpO 2 during OSA, but not OSA duration, were significantly associated with PR changes during BP surges. After adjusting for REM sleep, the lowest SpO 2 during OSA was significantly associated with PR change during the maximum value of BP surge but was not associated with PR change during nocturnal SBP surge (Table S5 ).
Discussion
In this study, we investigated BP level at the end of an OSA episode using a newly developed TNP method and demonstrated that the characteristics of the preceding OSA episode could influence the magnitude of BP surge in patients with OSA. Hypoxia-peak SBP was higher in REM sleep than in non-REM sleep. Nocturnal SBP surge and maximum value of SBP surge increased in REM sleep as compared with non-REM sleep. Both OSA duration and lowest SpO 2 during OSA were associated with hypoxia-peak SBP, nocturnal SBP surge, and maximum value of SBP surge. These findings suggest that each OSA episode has different hemodynamic effects according to different characteristics. Because exaggerated high BP at the time of OSA termination may contribute to adverse cardiovascular consequences, 5 our results indicate that the AHI and oxygen desaturation index, which are traditional scores used to determine the severity of OSA and are defined regardless of the characteristics of OSA, cannot fully estimate the risk for CVD.
Several recent longitudinal studies reported that OSA during REM sleep, but not OSA during non-REM sleep, is associated with prevalent and incident hypertension, 25, 26 as well as poor glycemic control in diabetes mellitus. 27 In a large-scale, randomized controlled trial, insufficient continuous positive airway pressure therapy of 3.3 hours per night did not prevent CVD in patients with moderate-to-severe OSA but significantly reduced daytime sleepiness, 28 which was associated with non-REM sleep but not REM sleep. 29 The limited Nocturnal SBP surge was defined as the difference between the hypoxia-peak SBP and the average of SBP values measured using the fixed-interval function. Maximum value of SBP surge was defined as the difference between the hypoxia-peak SBP and the minimum nocturnal SBP. AF indicates atrial fibrillation; BMI, body mass index; REM, rapid eye movement; and SBP, systolic blood pressure.
continuous positive airway pressure use may result in lack of treatment for most OSA during REM sleep because REM sleep is mostly concentrated in the second half of the sleep period. These lines of evidence suggest that OSA during REM sleep may play a critical role in increasing risk for CVD. REM sleep is characterized by increased sympathetic activation, reduced vagal tone, and decreased baroreceptor regulation, leading to increasing hemodynamic stress on vessel walls through increased BP, heart rate, and myocardial oxygen demand. 14, 30 Alterations in coronary blood flow during REM sleep were also reported. 31 However, little is known about the intermediate pathway between these physiological conditions during REM sleep and the adverse cardiovascular impact of OSA. In this study, we demonstrated that BP level, especially hypoxia-peak SBP, at the end of an OSA episode was higher in REM sleep than in non-REM sleep in real-world patients with OSA. Our results suggest that an OSA episode during the physiological condition of REM sleep causes exaggerated BP surge as compared with that in non-REM sleep. This may be related to the high prevalence of cardiovascular events from midnight to early morning in patients with OSA. 6, 7 Respiratory effort in response to upper airway occlusion in OSA patients is low during REM sleep as compared with that during non-REM sleep, resulting in longer OSA duration in REM sleep. 32 This may be because of REM-induced hypotonia of the major upper airway dilating muscle (genioglossus) 33 and decreased respiratory drive. Douglas et al 34, 35 reported that both hypoxic ventilatory response and hypercapnic ventilatory response decreased during REM sleep as compared with that during non-REM sleep. Both the longer OSA duration and the decreased ventilatory drive contribute to greater oxygen desaturation during REM sleep than during non-REM sleep. Therefore, there are close inter-relationships between sleep stage, OSA duration, and lowest SpO 2 during OSA. In this study, multivariate analysis revealed that lowest SpO 2 during OSA was associated with BP level at the end of OSA, independent of sleep stage, whereas OSA duration was not. These results suggest that sleep stage and the severity of oxygen desaturation may be primary determinants for the magnitude of BP surge caused by OSA. Both REM sleep and oxygen desaturation 36 activate the sympathetic nervous system. However, there was no significant synergistic effect on BP surge between the lowest SpO 2 during OSA and REM sleep. The chemoreflex response and arousals from sleep 37 evoked by oxygen desaturation might contribute to BP surge through additive effects on increased sympathetic activity during REM sleep because the lowest SpO 2 during OSA was significantly associated with PR change during BP surge. Even in the case of a slight change in sympathetic tonus, inflammatory vascular disease caused repetitive hypoxic episodes would enhance the BP variability more extensively in the OSA patients.
Our study has some limitations. First, there may be some selection bias in the study population because the subjects were restricted to those who had agreed to use the TNP method on the sleep study night. Second, the TNP system initiates BP measurement when the oxygen saturation level falls below a variable threshold. Therefore, our study did not include OSA episodes without oxygen desaturation above the setting level, resulting in high BP measurement rate of OSA episodes during REM sleep as compared with non-REM sleep. Third, we did not account for the number of trips patients made to the bathroom during the night of the experiment although the frequency of such trips could affect the mean nocturnal SBP.
38,39

Perspectives
The newly developed TNP method can catch nocturnal BP surge evoked by an OSA episode in actual patients under realworld conditions. Because nocturnal BP surge may play a critical role in the development of CVD, assessments of nocturnal BP by the TNP method may provide useful new markers to identify high-risk patients.
In this study, we demonstrated that characteristics of an OSA episode, including the specific sleep stage and severity of oxygen desaturation, were associated with the magnitude of BP surge, using TNP method. Our results indicate that each OSA episode has different hemodynamic effects depending on its characteristics, suggesting that the AHI and oxygen desaturation index, which are traditional scores used to determine the severity of OSA regardless of OSA characteristics, cannot fully estimate the risk of CVD. OSA during REM sleep causes high BP at the end of an OSA episode as compared with that during non-REM sleep. To prevent the exaggerated high BP, continuous positive airway pressure therapy may be required from midnight to early morning because REM sleep is mostly concentrated in the second half of the sleep period. This might be a critical determinant for prevention of CVD in patients with OSA.
